RNA sequencing can contribute to the development of a reliable drug recommendation tool

October 12, 2018 Leave a comment 2,017 Views

A new precision medicine platform utilizing both DNA and RNA sequencing helps identify targeted therapy options for patients with relapsed or refractory multiple myeloma. Multiple myeloma (MM) is a malignancy of plasma cells, with a median survival...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Icahn School of Medicine Mount Sinai

RNA sequencing can contribute to the development of a reliable drug recommendation tool

Mim-tRNAseq – A method that accurately measures the abundance and modification status of different tRNAs

Uncovering the Anti-Myeloma Resistance Files

Long term and short-term effects of RNA fixation on Single Cell RNA Sequencing

Single cell RNA sequencing opens new avenues for eradicating leukaemia at its source

2passtools: two-pass alignment using machine-learning-filtered splice junctions increases the accuracy of intron detection in long-read RNA sequencing

scRNA-Seq reveals a new type of bone cell that may uncover therapeutic targets for a range of skeletal diseases

DEBKS – a tool to detect differentially expressed circular RNA